Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 407509, 7 pages
http://dx.doi.org/10.1155/2014/407509
Research Article

Effect of “Jian-Pi-Zhi-Dong Decoction” on Gamma-Aminobutyric Acid in a Mouse Model of Tourette Syndrome

1Department of Pediatrics, Dongfang Hospital, Beijing University of Traditional Chinese Medicine, Beijing 100078, China
2School of Nursing, Taishan Medical University, Taian 271016, China

Received 9 January 2014; Accepted 18 March 2014; Published 9 April 2014

Academic Editor: Pinar Atukeren

Copyright © 2014 Wen Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Du, T. Chiu, K. Lee et al., “Tourette syndrome in children: an updated review,” Pediatrics and Neonatology, vol. 51, no. 5, pp. 255–264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. F. Leckman, M. H. Bloch, L. Scahill, and R. A. King, “Tourette syndrome: the self under siege,” Journal of Child Neurology, vol. 21, no. 8, pp. 642–649, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Verdellen, J. van de Griendt, A. Hartmann et al., “European clinical guidelines for Tourette syndrome and other tic disorders, part III: behavioural and psychosocial interventions,” European Child and Adolescent Psychiatry, vol. 20, no. 4, pp. 197–207, 2011. View at Google Scholar
  4. R. L. Albin and J. W. Mink, “Recent advances in Tourette syndrome research,” Trends in Neurosciences, vol. 29, no. 3, pp. 175–182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. F. Wong, J. R. Brašić, H. S. Singer et al., “Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET,” Neuropsychopharmacology, vol. 33, no. 6, pp. 1239–1251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Lv, A. Li, H. Ma, F. Liu, and H. Xu, “Effects of Ningdong granule on the dopamine system of Tourette's syndrome rat models,” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 488–492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. T. D. L. Steeves, J. H. Ko, D. M. Kideckel et al., “Extrastriatal dopaminergic dysfunction in Tourette syndrome,” Annals of Neurology, vol. 67, no. 2, pp. 170–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Roessner, K. J. Plessen, A. Rothenberger et al., “Erratum: European clinical guidelines for Tourette syndrome and other tic disorders, part II: pharmacological treatment, European Child and Adolescent Psychiatry, vol. 20, no. 4, pp. 173–196, 2011,” European Child and Adolescent Psychiatry, vol. 20, no. 7, p. 377, 2011. View at Google Scholar · View at Scopus
  9. J. L. R. Rubenstein and M. M. Merzenich, “Model of autism: increased ratio of excitation/inhibition in key neural systems,” Genes, Brain and Behavior, vol. 2, no. 5, pp. 255–267, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. F. Leckman, “Tourette's syndrome,” The Lancet, vol. 360, no. 9345, pp. 1577–1586, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Wang, F. Qi, J. Li et al., “Effects of Chinese herbal medicine Ningdong Granule on regulating dopamine (DA)/serotonin (5-TH) and gamma-amino butyric acid (GABA) in patients with Tourette syndrome,” Bioscience Trends, vol. 6, no. 4, pp. 212–218, 2012. View at Google Scholar
  12. Y. Tian, J. R. Gunther, I. H. Liao et al., “GABA- and acetylcholine-related gene expression in blood correlate with tic severity and microarray evidence for alternative splicing in Tourette syndrome: a pilot study,” Brain Research, vol. 1381, pp. 228–236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. Thorne Research Inc, “Gamma-aminobutyric acid (GABA),” Alternative Medicine Review, vol. 12, no. 3, pp. 274–279, 2007. View at Google Scholar
  14. A. Lerner, A. Bagic, J. M. Simmons et al., “Widespread abnormality of the gamma-aminobutyric acid-ergic system in Tourette syndrome,” Brain, vol. 135, pp. 1926–1936, 2012. View at Google Scholar
  15. M. A. Martinez-Granero, A. Garcia-Perez, and F. Montanes, “Levetiracetam as an alternative therapy for Tourette syndrome,” Neuropsychiatric Disease and Treatment, vol. 6, pp. 309–316, 2010. View at Google Scholar
  16. S. Sekine, S. Matsumoto, A. Issiki, T. Kitamura, J. Yamada, and Y. Watanabe, “Changes in expression of GABAAα4 subunit mRNA in the brain under anesthesia induced by volatile and intravenous anesthetics,” Neurochemical Research, vol. 31, no. 3, pp. 439–448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D.-H. Wang, W. Li, X.-F. Liu et al., “Chinese medicine formula, “Jian-Pi-Zhi-Dong Decoction” Attenuates Tourette syndrome via downregulating the expression of dopamine transporter in mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 385685, 9 pages, 2013. View at Publisher · View at Google Scholar
  18. H. A. Khan, A. S. Alhomida, and I. A. Arif, “Neurovestibular toxicities of acrylonitrile and iminodipropionitrile in rats: a comparative evaluation of putative mechanisms and target sites,” Toxicological Sciences, vol. 109, no. 1, pp. 124–131, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Wu, R. Wang, Q. Jiang et al., “Determination of amino acid neurotransmitters in rat hippocampi by HPLCUV using NBDF as a derivative,” Biomedical Chromatography, vol. 28, no. 4, pp. 459–462, 2014. View at Google Scholar
  20. H. Hörtnagl, R. Tasan, A. Wieselthaler et al., “Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain,” Neuroscience, vol. 236, pp. 345–372, 2013. View at Google Scholar
  21. X. Cui, L. Wei, S. M. Wang et al., “influence and mechanism of Jianpizhidong Decoction on autonomic activities in mouse model of Tourette’s syndrome,” Journal of Beijing University of Traditional Chinese Medicine, vol. 18, no. 1, pp. 1–4, 2011. View at Google Scholar
  22. L. Wei, S. M. Wang, G. X. Yue et al., “Effects of Jianpizhidong Decoction on dopamine pathway in striatum of TS model mice,” Chinese Journal of Information on Traditional Chinese Medcine, vol. 16, no. 12, pp. 38–40, 2009. View at Google Scholar
  23. K. Ramamoorthi and Y. Lin, “The contribution of GABAergic dysfunction to neurodevelopmental disorders,” Trends in Molecular Medicine, vol. 17, no. 8, pp. 452–462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. S. A. Anderson, D. D. Eisenstat, L. Shi, and J. L. R. Rubenstein, “Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes,” Science, vol. 278, no. 5337, pp. 474–476, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. O. Marín, S. A. Anderson, and J. L. R. Rubenstein, “Origin and molecular specification of striatal interneurons,” Journal of Neuroscience, vol. 20, no. 16, pp. 6063–6076, 2000. View at Google Scholar · View at Scopus
  26. Z. J. Huang, G. di Cristo, and F. Ango, “Development of GABA innervation in the cerebral and cerebellar cortices,” Nature Reviews Neuroscience, vol. 8, no. 9, pp. 673–686, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. P. S. A. Kalanithi, W. Zheng, Y. Kataoka et al., “Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 37, pp. 13307–13312, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Kataoka, P. S. A. Kalanithi, H. Grantz et al., “Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with tourette syndrome,” Journal of Comparative Neurology, vol. 518, no. 3, pp. 277–291, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. G. Dopico, J. P. Diaz, T. J. Alonso et al., “Extracellular taurine in the substantia nigra: Taurine-glutamate interaction,” Journal of Neuroscience Research, vol. 76, no. 4, pp. 528–538, 2004. View at Google Scholar
  30. J. G. Dopico, T. González-Hernández, I. M. Pérez et al., “Glycine release in the substantia nigra: interaction with glutamate and GABA,” Neuropharmacology, vol. 50, no. 5, pp. 548–557, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Galvan, M. Kuwajima, and Y. Smith, “Glutamate and GABA receptors and transporters in the basal ganglia: what does their subsynaptic localization reveal about their function?” Neuroscience, vol. 143, no. 2, pp. 351–375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. H. S. Singer, J. Wendlandt, M. Krieger, and J. Giuliano, “Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial,” Neurology, vol. 56, no. 5, pp. 599–604, 2001. View at Google Scholar · View at Scopus
  33. Y. Awaad, “Tics in Tourette syndrome: new treatment options,” Journal of Child Neurology, vol. 14, no. 5, pp. 316–319, 1999. View at Google Scholar · View at Scopus